SEC Filings | Structure Therapeutics

Filing date	Form	Description	View
Feb 06, 2024	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000902219-24-000007.pdf 0000902219-24-000007.rtf 0000902219-24-000007.xls
Dec 27, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-23-059755.pdf 0001209191-23-059755.rtf 0001209191-23-059755.xls
Dec 20, 2023	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000921895-23-002786.pdf 0000921895-23-002786.rtf 0000921895-23-002786.xls
Dec 18, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-126639.pdf 0001104659-23-126639.rtf 0001104659-23-126639.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Dec 07, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-23-057698.pdf 0001209191-23-057698.rtf 0001209191-23-057698.xls
Nov 29, 2023	EFFECT	EFFECT	View HTML 9999999995-23-003494.pdf 9999999995-23-003494.rtf 9999999995-23-003494.xls
Nov 27, 2023	CORRESP	CORRESP	View HTML 0001104659-23-121152.pdf 0001104659-23-121152.rtf 0001104659-23-121152.xls
Nov 24, 2023	UPLOAD	UPLOAD	View HTML 0000000000-23-012838.pdf 0000000000-23-012838.rtf
Nov 24, 2023	UPLOAD	UPLOAD	View HTML 0000000000-23-012839.pdf 0000000000-23-012839.rtf
Nov 20, 2023	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	View HTML 0001104659-23-119958.pdf 0001104659-23-119958.rtf 0001104659-23-119958.xls

Data provided by Kaleidoscope.